Why Ocugen's Stock Is Trading Higher Today

Ocugen OCGN shares are trading higher after the company announced it's on track to submit its Emergency Use Authorization application to the FDA for its COVID-19 vaccine candidate, COVAXIN.

Ocugen's stock is trading up 10.5% to a price of $8.4. The stock's volume is currently 45.45 million, which is roughly 46.82% of its recent 30-day volume average of 97.08 million.

The stock's 50-day moving average was $8.52 at the time this article was published. Over the past fifty-two weeks, the price has risen as high as $18.77 and fallen to a low of $0.17.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.